Northern Trust Corp Akouos, Inc. Transaction History

Northern Trust Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.6 - $5.16 $6,760 - $13,416	-2,600 Reduced 6.45%	37,685 $255,000
Q2 2022 Aug 12, 2022	SELL	$2.46 - $5.2 $393,981 - $832,806	-160,155 Reduced 79.9%	40,285 $189,000
Q1 2022 May 13, 2022	SELL	$4.16 - $9.08 $45,385 - $99,062	-10,910 Reduced 5.16%	200,440 $952,000
Q4 2021 Feb 08, 2022	SELL	$7.65 - $11.38 $84,838 - $126,204	-11,090 Reduced 4.99%	211,350 $1.8 Million
Q3 2021 Nov 15, 2021	BUY	$9.93 - $13.59 $94,265 - $129,009	9,493 Added 4.46%	222,440 $2.58 Million
Q2 2021 Aug 13, 2021	SELL	$11.87 - $15.96 $273,223 - $367,367	-23,018 Reduced 9.75%	212,947 $2.67 Million
Q1 2021 May 12, 2021	BUY	$13.87 - $21.04 $924,560 - $1.4 Million	66,659 Added 39.37%	235,965 $3.27 Million
Q4 2020 Feb 11, 2021	BUY	$17.03 - $22.45 $26,583 - $35,044	1,561 Added 0.93%	169,306 $3.36 Million
Q3 2020 Nov 16, 2020	BUY	$19.3 - $26.92 $3.24 Million - $4.52 Million	167,745 New	167,745 $3.84 Million

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.